Slow drip, less pain: new study aims to prevent chemo nerve damage
NCT ID NCT03800693
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving the chemotherapy drug oxaliplatin over 6 hours instead of the usual 2 hours can prevent or delay nerve damage in people with gastrointestinal cancers. About 60 participants will be randomly assigned to one of two infusion times. The goal is to see if the longer infusion allows patients to stay on full-dose treatment longer without delays or dose reductions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT DIGESTIVE SYSTEM NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory Saint Joseph's Hospital
RECRUITINGAtlanta, Georgia, 30342, United States
-
Emory University Hospital Midtown
RECRUITINGAtlanta, Georgia, 30308, United States
-
Emory University Hospital/Winship Cancer Institute
RECRUITINGAtlanta, Georgia, 30322, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New program aims to make cancer surgery safer for seniors
- Heart-Safe chemo? new study tests vasodilators to prevent chest pain in cancer patients
- Can acupuncture and ice chips beat chemo nerve damage?
- New stent procedure aims to ease complications in GI cancer patients
- New algorithm aims to keep chemo on track for stomach and colon cancers
- Smart devices track cancer recovery at home